APOC3 and coronary artery disorder: An increased apoC-III/HDL ratio was shown to be associated with CAD as a result of impaired cholesterol efflux capacity [186], suggesting that reducing the apoC-III/HDL ratio through targeting apoC-III by ASO may prove to be protective against CAD.